Current status and trends of resistance to cefotaxime in several dominating clinical pathogenic bacteria
Abstract：The third-generation cephalosporin cefotaxime has been widely used in clinic because of its ex-cellent antimicrobial effect and broad antibiotic spectrum. However, most of pathogenic bacteria have developed se-vere drug-resistance, which is threatening the common use of this antibiotic. Here, we reviewed current data con-cerning drug-resistance to cefotaxime among several clinical dominating pathogenic bacteria, including their distri-bution, β-lactamase production as well as its changes.
Keywords：cefotaximeantibiotic-resistanceβ-lactamasesantibacterial agents
Publication Date：2010-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)